Marvel Biosciences Corp.: Marvel Biosciences Announces Closing of First Tranche of Debenture Offering

Calgary, Alberta--(Newsfile Corp. - February 24, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) ("Marvel" or the "Corporation") announced today that it has completed the closing of the first tranche of

Related Keywords

Dennis Riedl ,J Roderick Matheson ,Mark Williams ,Good Lab Practice ,Marvel Biosciences Corp ,Marvel Biotechnology Inc ,Corporation Common ,Party Policies ,Virtus Advisory Group ,Alberta Newsfile Corp ,Venture Exchange ,Regulation Services Provider ,Common Shares ,Common Share ,Private Placement ,Exchange Policy ,Multilateral Instrument ,Related Party Policies ,Formal Valuation ,Not Listed ,Specified Markets ,Minority Approval ,Market Value Note More Than ,Biosciences Corp ,Chief Executive Officer ,Chief Science ,Marvel ,Iosciences ,Orp ,Nnounces ,Closing ,First ,Tranche ,Debenture ,Offering ,